02420 ZIBUYU
- 4.050
- +0.040+1.00%
ZIBUYU News
ZIBUYU: 2024 INTERIM REPORT
Interview with Zibuyu (02420): Leading the new trend of transformation and upgrading of cross-border e-commerce, with a nearly eightfold year-on-year increase in net profit for the mid-term performance of 2024.
Mr. Chen Caixiong, the executive director and CEO of Zi Buyu Group, joined the Zi Buyu family in March 2023 and has rich experience in supply chain management and enterprise management. He shared the company's development process and future plans in the cross-border e-commerce industry during an interview with Zhitong Finance.
Zibuyu Group Announces Board Structure
Zibuyu Group Limited Unveils Mid-Year Financials
Zibuyu (02420) releases interim performance, with a net profit attributable to shareholders of approximately 91.365 million yuan, an increase of about 8 times year-on-year.
Zibuyu (02420) announced the interim performance for the six months ended June 30, 2024, during which the group achieved revenue...
Chen Caixiong was appointed as an executive director at Zibuyu (02420).
Zibo Yu (02420) announced that Huabing Rong, the executive director of the company and chairman and co-CEO of the board of directors, resigned due to work safety...
ZIBUYU: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Express News | Zibuyu Group Ltd - Chen Caixiong Appointed as Executive Director
Express News | Zibuyu Group Ltd - Hua Bingru Resigned as a Co-CEO
Zibuyu Group Prepares for Major Financial Decisions
Zibuyu (02420.HK) plans to hold a board of directors meeting on August 29th to review the mid-term performance.
On August 19th, GeLongHui announced that the board of directors meeting will be held on August 29th, 2024 (Thursday) to consider approving the group's interim performance ending on June 30th, 2024 and its release, including recommending the distribution of interim dividends (if any).
Zibuyu Group Expects Up to 842% Surge in H1 Profit
Zibuyu Group Expects Substantial Profit Growth
Zibuyu (02420.HK) Yingxi: It is expected that the net income in the first half of the year will increase by about 745%-842% year-on-year.
On August 1st, Glory Medical (02420.HK) announced that the group is expected to record a net income between about RMB 87 million and about RMB 97 million for the six months ending June 30, 2024, compared to a net income of about RMB 10.3 million for the six months ending June 30, 2023, an expected year-on-year increase of about 745% to 842%. This is mainly due to the following events: (i) continuous increase in income, resulting in corresponding increase in gross profit; (ii) reducing inventory levels and optimizing inventory structure, resulting in a decrease in warehousing costs; and (iii) adjusting personnel structure and improving operation efficiency.
Express News | Zibuyu Group - Expected Result Due to Decrease in Warehousing Costs, Others
Express News | Zibuyu Group Ltd Sees Net Profit in Range of RMB87 Mln to RMB97 Mln for Six Months
Express News | Zibuyu Group H1 Net Income RMB 87 Million
ZIBUYU: POSITIVE PROFIT ALERT
Zibuyu Group Limited's (HKG:2420) Most Bullish Insider, CEO Bingru Hua Must Be Pleased With the Recent 27% Gain
Perspectives Don't Speak (02420) Financial Report: Inventory Optimization, Smooth and Lightweight Launch Brings Growth Resilience
In the future, focusing on high-quality development as an anchor, Zi Bu Yu will continue to expand non-Amazon channels, offline channels, and European and Asian markets, increase brand investment, strengthen the overseas layout of the supply chain, and rely on digital construction to improve operational efficiency. With many measures taken together, the unspoken growth prospects are still worth the market's expectations.
Analysis
Price Target
No Data
No Data